April 10th, 2018
In the past year,
Blue Shield of California (BSC) has begun the process of dropping their coverage of viscosupplements (intraarticular
hyaluronic acid injections) for
osteoarthritis of the knee.
June 1st, 2018, patients covered under Blue Shield of California commercial health insurance,
will no longer receive ANY coverage for viscosupplementation treatment
for osteoarthritis of the knee. This change has been implemented based
on scientific reviews and guidelines that have determined this method
of treatment is not considered to be “medically necessary.”
Medically necessary is defined by
Medicare.gov as a healthcare service or supply needed to prevent, diagnose or treat
an illness, injury, condition, disease or its symptoms and that meet accepted
standards of medicine.
For those patients who have received an approved authorization for viscosupplementation:
Treatment plan will need to be completed prior to June 1st in order to be covered.
For those patients who have been prescribed a series of three viscosupplementation
All three treatments will need to be done prior to June 1st.
NOTE: It is anticipated that other health insurance plans may follow BSC’s
lead and also stop coverage of viscosupplementations. We will attempt
to update our Blog with any new information. However, it is best to contact
your health plan directly to confirm authorization approval for this type
If you have any questions about treatment options, give us a call at (949)
722-7038 and set up an
appointment with your doctor.